Walleye Capital
LLY icon

Walleye Capital’s Eli Lilly LLY Stock Holding History

Walleye Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19M Sell
20,644
-15,497
-43% -$15.7M 0.08% 210
2025
Q4 		$38.8M Buy
36,141
+18,046
+100% +$17.3M 0.12% 103
2025
Q3 		$13.8M Sell
18,095
-727
-4% -$541K 0.05% 399
2025
Q2 		$14.7M Buy
18,822
+13,335
+243% +$10.4M 0.06% 357
2025
Q1 		$4.53M Sell
5,487
-1,880
-26% -$1.56M 0.02% 851
2024
Q4 		$5.69M Sell
7,367
-45,636
-86% -$37.8M 0.01% 990
2024
Q3 		$47M Buy
53,003
+34,164
+181% +$30.7M 0.1% 130
2024
Q2 		$17.1M Buy
18,839
+1,148
+6% +$918K 0.03% 436
2024
Q1 		$13.8M Buy
17,691
+4,599
+35% +$3.27M 0.02% 621
2023
Q4 		$7.63M Buy
+13,092
New +$7.64M 0.02% 833
2023
Q3 		– Sell
-348
Closed -$179K – 5129
2023
Q2 		$163K Sell
348
-86,350
-100% -$36.2M ﹤0.01% 3206
2023
Q1 		$29.8M Buy
+86,698
New +$29.2M 0.45% 12
2022
Q4 		– Sell
-12,601
Closed -$4.47M – 3436
2022
Q3 		$4.08M Buy
12,601
+7,075
+128% +$2.24M 0.08% 276
2022
Q2 		$1.79M Buy
+5,526
New +$1.66M 0.05% 396
2022
Q1 		– Sell
-22,167
Closed -$6.12M – 2444
2021
Q4 		$6.12M Buy
+22,167
New +$5.62M 0.19% 113
2021
Q3 		– Sell
-16,592
Closed -$3.81K – 1716
2021
Q2 		$3.81K Sell
16,592
-10,052
-38% -$2.02M 0.13% 120
2021
Q1 		$4.98K Buy
26,644
+7,547
+40% +$1.48M 0.29% 46
2020
Q4 		$3.22K Buy
+19,097
New +$2.85M 0.22% 75
2020
Q1 		– Sell
-960
Closed -$132K – 1349
2019
Q4 		$126K Buy
960
+590
+159% +$68.4K 0.01% 1302
2019
Q3 		$41K Hold
370
– – ﹤0.01% 1639
2019
Q2 		$41K Buy
370
+170
+85% +$20K ﹤0.01% 1418
2019
Q1 		$26K Buy
+200
New +$24.3K ﹤0.01% 1318

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Walleye Capital's LLY Position: Q1 2026 in Review

Walleye Capital reduced its Eli Lilly (LLY) stake by 43% in Q1 2026, selling an estimated $15.7M and leaving 20,644 shares worth $19M. The position accounts for 0.08% of the portfolio, ranked #210.

Walleye Capital first reported a position in LLY in Q1 2019 and has held it in 22 quarters since. The position peaked at $47M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Walleye Capital held 20,644 shares of Eli Lilly worth $19M as of Q1 2026.
  • Walleye Capital sold 15,497 Eli Lilly shares in Q1 2026, an estimated $15.7M.
  • Eli Lilly made up 0.08% of Walleye Capital's portfolio in Q1 2026, its #210 holding.
  • Walleye Capital first reported a position in Eli Lilly in Q1 2019 and has held it in 22 quarters since.
  • Walleye Capital's Eli Lilly position peaked at $47M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.